441 related articles for article (PubMed ID: 17238215)
1. Nuchal translucency measurement and congenital heart defects: modest association in low-risk pregnancies.
Müller MA; Clur SA; Timmerman E; Bilardo CM
Prenat Diagn; 2007 Feb; 27(2):164-9. PubMed ID: 17238215
[TBL] [Abstract][Full Text] [Related]
2. [The role of fetal nuchal translucency (NT) and ductus venosus blood flow (DV) in the detection of congenital heart defects].
Baś-Budecka E; Perenc M; Sieroszewski P
Ginekol Pol; 2010 Apr; 81(4):272-6. PubMed ID: 20476599
[TBL] [Abstract][Full Text] [Related]
3. Is measurement of nuchal translucency thickness a useful screening tool for heart defects? A study of 16,383 fetuses.
Westin M; Saltvedt S; Bergman G; Almström H; Grunewald C; Valentin L
Ultrasound Obstet Gynecol; 2006 Jun; 27(6):632-9. PubMed ID: 16715530
[TBL] [Abstract][Full Text] [Related]
4. [Ultrasound soft markers and fetal cardiac structural assessment at 11-14 weeks].
Yang Y; Zhang Y
Zhonghua Fu Chan Ke Za Zhi; 2014 Mar; 49(3):188-92. PubMed ID: 24820303
[TBL] [Abstract][Full Text] [Related]
5. Limitations of using first-trimester nuchal translucency measurement in routine screening for major congenital heart defects.
Mavrides E; Cobian-Sanchez F; Tekay A; Moscoso G; Campbell S; Thilaganathan B; Carvalho JS
Ultrasound Obstet Gynecol; 2001 Feb; 17(2):106-10. PubMed ID: 11251916
[TBL] [Abstract][Full Text] [Related]
6. Fetal echocardiography at the time of the nuchal translucency scan.
Lombardi CM; Bellotti M; Fesslova V; Cappellini A
Ultrasound Obstet Gynecol; 2007 Mar; 29(3):249-57. PubMed ID: 17318942
[TBL] [Abstract][Full Text] [Related]
7. Detailed screening for fetal anomalies and cardiac defects at the 11-13-week scan.
Becker R; Wegner RD
Ultrasound Obstet Gynecol; 2006 Jun; 27(6):613-8. PubMed ID: 16570262
[TBL] [Abstract][Full Text] [Related]
8. Cardiac malformations in first-trimester fetuses with increased nuchal translucency: ultrasound diagnosis and postmortem morphology.
Haak MC; Bartelings MM; Gittenberger-De Groot AC; Van Vugt JM
Ultrasound Obstet Gynecol; 2002 Jul; 20(1):14-21. PubMed ID: 12100412
[TBL] [Abstract][Full Text] [Related]
9. Increased nuchal translucency and congenital heart defects in a low-risk population.
Hafner E; Schuller T; Metzenbauer M; Schuchter K; Philipp K
Prenat Diagn; 2003 Dec; 23(12):985-9. PubMed ID: 14663835
[TBL] [Abstract][Full Text] [Related]
10. Abnormal first-trimester ductus venosus blood flow: a marker of cardiac defects in fetuses with normal karyotype and nuchal translucency.
Martínez JM; Comas M; Borrell A; Bennasar M; Gómez O; Puerto B; Gratacós E
Ultrasound Obstet Gynecol; 2010 Mar; 35(3):267-72. PubMed ID: 20052662
[TBL] [Abstract][Full Text] [Related]
11. The nuchal translucency and the fetal heart: a literature review.
Clur SA; Ottenkamp J; Bilardo CM
Prenat Diagn; 2009 Aug; 29(8):739-48. PubMed ID: 19399754
[TBL] [Abstract][Full Text] [Related]
12. Nuchal translucency and cystic hygroma colli in screening for fetal major congenital heart defects in a series of 12,910 euploid pregnancies.
Sananes N; Guigue V; Kohler M; Bouffet N; Cancellier M; Hornecker F; Hunsinger MC; Kohler A; Mager C; Neumann M; Schmerber E; Tanghe M; Nisand I; Favre R
Ultrasound Obstet Gynecol; 2010 Mar; 35(3):273-9. PubMed ID: 20069678
[TBL] [Abstract][Full Text] [Related]
13. Fetal cardiac defects and increased nuchal translucency thickness: a prospective study.
McAuliffe FM; Hornberger LK; Winsor S; Chitayat D; Chong K; Johnson JA
Am J Obstet Gynecol; 2004 Oct; 191(4):1486-90. PubMed ID: 15507988
[TBL] [Abstract][Full Text] [Related]
14. The role of fetal nuchal translucency and ductus venosus Doppler at 11-14 weeks of gestation in the detection of major congenital heart defects.
Favre R; Cherif Y; Kohler M; Kohler A; Hunsinger MC; Bouffet N; Tanghe M; Cancellier M; Nisand I
Ultrasound Obstet Gynecol; 2003 Mar; 21(3):239-43. PubMed ID: 12666217
[TBL] [Abstract][Full Text] [Related]
15. Increased nuchal translucency thickness and normal karyotype: time for parental reassurance.
Bilardo CM; Müller MA; Pajkrt E; Clur SA; van Zalen MM; Bijlsma EK
Ultrasound Obstet Gynecol; 2007 Jul; 30(1):11-8. PubMed ID: 17559183
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis of major heart defects by routine first-trimester ultrasound examination: association with increased nuchal translucency, tricuspid regurgitation and abnormal flow in ductus venosus.
Minnella GP; Crupano FM; Syngelaki A; Zidere V; Akolekar R; Nicolaides KH
Ultrasound Obstet Gynecol; 2020 May; 55(5):637-644. PubMed ID: 31875326
[TBL] [Abstract][Full Text] [Related]
17. Nuchal translucency and the risk of congenital heart disease.
Simpson LL; Malone FD; Bianchi DW; Ball RH; Nyberg DA; Comstock CH; Saade G; Eddleman K; Gross SJ; Dugoff L; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; Tripp T; D'Alton ME
Obstet Gynecol; 2007 Feb; 109(2 Pt 1):376-83. PubMed ID: 17267839
[TBL] [Abstract][Full Text] [Related]
18. [Screening performance of first trimester nuchal translucency, ductus venosus blood flow and tricuspid regurgitation for cardiac defects].
Geipel A; Gembruch U
Z Geburtshilfe Neonatol; 2012 Aug; 216(4):157-61. PubMed ID: 22926815
[TBL] [Abstract][Full Text] [Related]
19. Relationship between nuchal translucency thickness and prevalence of major cardiac defects in fetuses with normal karyotype.
Atzei A; Gajewska K; Huggon IC; Allan L; Nicolaides KH
Ultrasound Obstet Gynecol; 2005 Aug; 26(2):154-7. PubMed ID: 15977311
[TBL] [Abstract][Full Text] [Related]
20. Nuchal translucency measurement and pregnancy outcome in karyotypically normal fetuses.
Michailidis GD; Economides DL
Ultrasound Obstet Gynecol; 2001 Feb; 17(2):102-5. PubMed ID: 11251915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
